Robin Fåhræus

Robin Fåhræus (1888–1968) was a Swedish physician and scientist known for his pioneering work in the field of hematology, the study of blood. His most notable contribution is the discovery of the Erythrocyte Sedimentation Rate (ESR), a common blood test used to detect inflammation that bears his name as the Fåhræus-Lindqvist effect.
Early Life and Education[edit]
Robin Fåhræus was born in 1888 in Sweden. From a young age, he showed a keen interest in the sciences, which led him to pursue a career in medicine. He received his medical degree from a prestigious University in Sweden, where he later also conducted his early research.
Career and Contributions[edit]
After completing his education, Fåhræus dedicated himself to research in hematology. In 1921, he made a groundbreaking discovery that the sedimentation rate of red blood cells increases in the presence of certain diseases, which led to the development of the ESR test. This test quickly became an essential diagnostic tool in medicine for detecting inflammation associated with various conditions, including infections, cancers, and autoimmune diseases.
Fåhræus's work extended beyond the ESR. He also made significant contributions to our understanding of blood viscosity and its relationship to blood vessel diameter, known as the Fåhræus-Lindqvist effect. His research in this area has had a profound impact on the field of cardiovascular medicine, influencing the development of treatments for heart and blood vessel diseases.
Throughout his career, Fåhræus received numerous awards and honors for his contributions to medicine and science. He was a member of several prestigious scientific societies and authored many scientific papers that have left a lasting legacy in the field of hematology.
Legacy[edit]
Robin Fåhræus's work has had a lasting impact on the field of medicine. The ESR test remains a fundamental tool in clinical diagnostics, used worldwide to help diagnose and monitor a wide range of diseases. His research into blood viscosity has also continued to influence the development of new treatments for cardiovascular diseases.
Death[edit]
Robin Fåhræus passed away in 1968, leaving behind a legacy as one of the most influential figures in the field of hematology. His discoveries continue to benefit medical science and patient care, demonstrating the enduring value of his contributions to health and medicine.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
